The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D

Journal of Biological Chemistry

Volumn 289, Issue 45, 2014, Pages 31576-31590

  Hagemann Jensen, Michael ^a   Uhlenbrock, Franziska ^a   Kehlet, Stephanie ^a   Andresen, Lars ^a   Gabel Jensen, Charlotte ^a   Ellgaard, Lars ^b   Gammelgaard, Bente ^a   Skov, Søren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; CELL DEATH; CELL MEMBRANES; CHEMICAL ACTIVATION; LYMPHOCYTES; METABOLITES; MICA; SELENIUM; SELENIUM COMPOUNDS; TUMORS;

ACTIVE METABOLITES; CELL SURFACE EXPRESSION; IMMUNE ACTIVATION; MALIGNANT TRANSFORMATIONS; POST-TRANSCRIPTIONAL; REACTIVE OXYGEN SPECIES; SURFACE TRANSPORT; TRANSPORT PATHWAYS;

LIGANDS;

DNA; LIGAND; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D; REACTIVE OXYGEN METABOLITE; SELENIUM; CALCIUM; HISTONE DEACETYLASE INHIBITOR; KLRK1 PROTEIN, HUMAN; METHANESELENOL; METHANOL; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; ORGANOSELENIUM DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURFACE; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; DNA DAMAGE; IMMUNOTHERAPY; MALIGNANT TRANSFORMATION; METABOLITE; NONHUMAN; PROTEIN EXPRESSION; RECOGNITION; TRANSCRIPTION INITIATION; ANALOGS AND DERIVATIVES; AUTOPHAGY; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; CYTOTOXICITY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; JURKAT CELL LINE; LYMPHOCYTE; MASS SPECTROMETRY; METABOLISM; NATURAL KILLER CELL; PROCEDURES; REPORTER GENE; RNA PROCESSING; TUMOR CELL LINE;

AUTOPHAGY; CALCIUM; CELL LINE, TUMOR; CELL MEMBRANE; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HISTONE DEACETYLASE INHIBITORS; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; JURKAT CELLS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTES; MASS SPECTROMETRY; METHANOL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; ORGANOSELENIUM COMPOUNDS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SELENIUM;

EID: 84910011170     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.591537     Document Type: Article

References (88)

1. Bauer, S. (1999) Activation ofNKCells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA. Science 285, 727-729
2. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L., and Spies, T. (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 100, 9452-9457
3. Groh, V., Smythe, K., Dai, Z., and Spies, T. (2006) Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat. Immunol. 7, 755-762
4. Vivier, E., Tomasello, E., and Paul, P. (2002) Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14, 306-311
5. Champsaur, M., and Lanier, L. L. (2010) Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 235, 267-285
6. Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., and Jung, H. (2013) Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31, 413-441
7. Andresen, L., Hansen, K. A., Jensen, H., Pedersen, S. F., Stougaard, P., Hansen, H. R., Jurlander, J., and Skov, S. (2009) Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells. J. Immunol. 183, 897-906
8. Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., and Chalupny, N. J. (2001) ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133
9. Gasser, S., Orsulic, S., Brown, E. J., and Raulet, D. H. (2005) The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190
10. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M., and Spies, T. (1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 93, 12445-12450
11. Jinushi, M., Takehara, T., Kanto, T., Tatsumi, T., Groh, V., Spies, T., Miyagi, T., Suzuki, T., Sasaki, Y., and Hayashi, N. (2003) Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170, 1249-1256
12. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Kimura, R., Miyagi, T., Mochizuki, K., Sasaki, Y., and Hayashi, N. (2003) Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 104, 354-361
13. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Suzuki, T., Miyagi, T., and Hayashi, N. (2003) Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression ofMHCclass I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 171, 5423-5429
14. Schreiner, B., Voss, J., Wischhusen, J., Dombrowski, Y., Steinle, A., Lochmüller, H., Dalakas, M., Melms, A., and Wiendl, H. (2006) Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J. 20, 118-120
15. Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., and Odum, N. (2005) Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65, 11136-11145
16. Valés-Gómez, M., Chisholm, S. E., Cassady-Cain, R. L., Roda-Navarro, P., and Reyburn, H. T. (2008) Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res. 68, 1546-1554
17. Nückel, H., Switala, M., Sellmann, L., Horn, P. A., Dürig, J., Dührsen, U., Küppers, R., Grosse-Wilde, H., and Rebmann, V. (2010) The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia 24, 1152-1159
18. Paschen, A. Sucker, A. Hill, B. Moll, I. Zapatka, M. Nguyen, X. D. Sim, G. C. Gutmann, I. Hassel, J. Becker, J. C. Steinle, A. Schadendorf, D. Ugurel, S. 2009 Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B Clin. Cancer Res. 15 5208-5215
19. Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., and Plymate, S. R. (2004) Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J. Clin. Invest. 114, 560-568
20. Roman, M., Jitaru, P., and Barbante, C. (2014) Selenium biochemistry and its role for human health. Metallomics 6, 25-54
21. Auger, J., Yang, W., Arnault, I., Pannier, F., and Potin-Gautier, M. (2004) High-performance liquid chromatographic-inductively coupled plasma mass spectrometric evidence for Se-"alliins" in garlic and onion grown in Se-rich soil. J. Chromatogr. A 1032, 103-107
22. Gammelgaard, B., Jackson, M. I., and Gabel-Jensen, C. (2011) Surveying selenium speciation from soil to cell: forms and transformations. Anal. Bioanal. Chem. 399, 1743-1763
23. Yan, L., and DeMars, L. C. (2012) Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. Int. J. Cancer 131, 1260-1266
24. Chen, Y. C., Prabhu, K. S., Das, A., and Mastro, A. M. (2013) Dietary selenium supplementation modifies breast tumor growth and metastasis. Int. J. Cancer 133, 2054-2064
25. Ip, C., Thompson, H. J., Zhu, Z., and Ganther, H. E. (2000) In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60, 2882-2886
26. Suzuki, K. T., Kurasaki, K., and Suzuki, N. (2007) Selenocysteine β-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide. Biochim. Biophys. Acta 1770, 1053-1061
27. Spallholz, J. E., Shriver, B. J., and Reid, T. W. (2001) Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Nutr. Cancer 40, 34-41
28. Esaki, N., Tanaka, H., Uemura, S., Suzuki, T., and Soda, K. (1979) Catalytic action of L-methionine γ-lyase on selenomethionine and selenols. Biochemistry 18, 407-410
29. Fernandes, A. P., Wallenberg, M., Gandin, V., Misra, S., Tisato, F., Marzano, C., Rigobello, M. P., Kumar, S., and Björnstedt, M. (2012) Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systems. PloS ONE 7, e50727
30. Gromer, S., and Gross, J. H. (2002) Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase: implications for the antitumor effects of selenium. J. Biol. Chem. 277, 9701-9706
31. Asfour, I. A., El-Tehewi, M. M., Ahmed, M. H., Abdel-Sattar, M. A., Moustafa, N. N., Hegab, H. M., and Fathey, O. M. (2009) High-dose sodium selenite can induce apoptosis of lymphoma cells in adult patients with non-Hodgkin's lymphoma. Biol. Trace Elem. Res. 127, 200-210
32. Brozmanová, J., Mániková, D., Vlčková, V., and Chovanec, M. (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch. Toxicol. 84, 919-938
33. Selenius, M., Rundlöf, A. K., Olm, E., Fernandes, A. P., and Björnstedt, M. (2010) Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer. Antioxid. Redox Signal. 12, 867-880
34. El-Bayoumy, K., Das, A., Narayanan, B., Narayanan, N., Fiala, E. S., Desai, D., Rao, C. V., Amin, S., and Sinha, R. (2006) Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. Carcinogenesis 27, 1369 -1376
35. Li, G. X., Lee, H. J., Wang, Z., Hu, H., Liao, J. D., Watts, J. C., Combs, G. F., Jr., and Lü, J. (2008) Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29, 1005-1012
36. Jiang, C., Wang, Z., Ganther, H., and Lu, J. (2001) Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res. 61, 3062-3070
37. Wang, Z., Jiang, C., and Lü, J. (2002) Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol. Mol. Carcinog. 34, 113-120
38. Zeng, H., Wu, M., and Botnen, J. H. (2009) Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J. Nutr. 139, 1613-1618
39. Jiang, C., Ganther, H., and Lu, J. (2000) Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Mol. Carcinog. 29, 236-250
40. Lee, J. I., Nian, H., Cooper, A. J., Sinha, R., Dai, J., Bisson, W. H., Dashwood, R. H., and Pinto, J. T. (2009) -Keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells. Cancer Prev. Res. (Phila.) 2, 683-693
41. Nian, H., Bisson, W. H., Dashwood, W. M., Pinto, J. T., and Dashwood, R. H. (2009) -Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells. Carcinogenesis 30, 1416-1423
42. Gopalakrishna, R., and Gundimeda, U. (2002) Antioxidant regulation of protein kinase C in cancer prevention. J. Nutr. 132, 3819S-3823S
43. Gundimeda, U., Schiffman, J. E., Chhabra, D., Wong, J., Wu, A., and Gopalakrishna, R. (2008) Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to seleniuminduced apoptosis in prostate cancer cells. J. Biol. Chem. 283, 34519-34531
44. Dong, Y., Ganther, H. E., Stewart, C., and Ip, C. (2002) Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res. 62, 708-714
45. Dong, Y., Zhang, H., Hawthorn, L., Ganther, H. E., and Ip, C. (2003) Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res. 63, 52-59
46. Yan, L., and Spallholz, J. E. (1993) Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem. Pharmacol. 45, 429-437
47. Reeves, P. G., Leary, P. D., Gregoire, B. R., Finley, J. W., Lindlauf, J. E., and Johnson, L. K. (2005) Selenium bioavailability from buckwheat bran in rats fed a modified AIN-93G torula yeast-based diet. J. Nutr. 135, 2627-2633
48. Micke, O., Bruns, F., Mücke, R., Schäfer, U., Glatzel, M., DeVries, A. F., Schönekaes, K., Kisters, K., and Büntzel, J. (2003) Selenium in the treatment of radiation-associated secondary lymphedema. Int. J. Radiat. Oncol. Biol. Phys. 56, 40-49
49. Klionsky, D. J., and Emr, S. D. (2000) Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721
50. Klionsky, D. J. (2013) Ancient autophagy. Autophagy 9, 445-446
51. Tal, M. C., and Iwasaki, A. (2009) Autophagy and innate recognition systems. Curr. Top. Microbiol. Immunol. 335, 107-121
52. Castillo, K., Valenzuela, V., Matus, S., Nassif, M., Oñate, M., Fuentealba, Y., Encina, G., Irrazabal, T., Parsons, G., Court, F. A., Schneider, B. L., Armentano, D., and Hetz, C. (2013) Measurement of autophagy flux in the nervous system in vivo. Cell Death Dis. 4, e917
53. Uhlenbrock, F., Hagemann-Jensen, M., Kehlet, S., Andresen, L., Pastorekova, S., and Skov, S. (2014) The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. J. Immunol. 193, 1654-1665
54. Andresen, L., Jensen, H., Pedersen, M. T., Hansen, K. A., and Skov, S. (2007) Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J. Immunol. 179, 8235-8242
55. Andreadou, I., Menge, W. M., Commandeur, J. N., Worthington, E. A., and Vermeulen, N. P. (1996) Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: evaluation of kinetics of -elimination reactions in rat renal cytosol. J. Med. Chem. 39, 2040-2046
56. Lunøe, K., Gabel-Jensen, C., Stürup, S., Andresen, L., Skov, S., and Gammelgaard, B. (2011) Investigation of the selenium metabolism in cancer cell lines. Metallomics 3, 162-168
57. Jensen, H., Hagemann-Jensen, M., Lauridsen, F., and Skov, S. (2013) Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment. Mol. Immunol. 53, 255-264
58. Skov, S., Rieneck, K., Bovin, L. F., Skak, K., Tomra, S., Michelsen, B. K., and Ødum, N. (2003) Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression. Blood 101, 1430-1438
59. Bauman, Y., Nachmani, D., Vitenshtein, A., Tsukerman, P., Drayman, N., Stern-Ginossar, N., Lankry, D., Gruda, R., and Mandelboim, O. (2011) An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9, 93-102
60. Nachmani, D., Lankry, D., Wolf, D. G., and Mandelboim, O. (2010) The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat Immunol 11, 806-813
61. O'Toole, D., Castle, L. E., and Raisbeck, M. F. (1995) Comparison of histochemical autometallography (Danscher's stain) to chemical analysis for detection of selenium in tissues. J. Vet. Diagn. Invest. 7, 281-284
62. Sandor, V., Bakke, S., Robey, R. W., Kang, M. H., Blagosklonny, M. V., Bender, J., Brooks, R., Piekarz, R. L., Tucker, E., Figg, W. D., Chan, K. K., Goldspiel, B., Fojo, A. T., Balcerzak, S. P., and Bates, S. E. (2002) Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin. Cancer Res. 8, 718-728
63. Berg, S. L., Stone, J., Xiao, J. J., Chan, K. K., Nuchtern, J., Dauser, R., McGuffey, L., Thompson, P., and Blaney, S. M. (2004) Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates. Cancer Chemother. Pharmacol. 54, 85-88
64. Rajgolikar, G., Chan, K. K., and Wang, H. C. (1998) Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells. Breast Cancer Res. Treat. 51, 29-38
65. Byrd, J. C., Shinn, C., Ravi, R., Willis, C. R., Waselenko, J. K., Flinn, I. W., Dawson, N. A., and Grever, M. R. (1999) Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 94, 1401-1408
66. Murata, M., Towatari, M., Kosugi, H., Tanimoto, M., Ueda, R., Saito, H., and Naoe, T. (2000) Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells. Jpn. J. Cancer Res. 91, 1154-1160
67. Gabel-Jensen, C., Lunøe, K., and Gammelgaard, B. (2010) Formation of methylselenol, dimethylselenide and dimethyldiselenide in in vitro metabolism models determined by headspace GC-MS. Metallomics 2, 167-173
68. Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M., and Masucci, M. G. (2000) Short-lived green fluorescent proteins for quantifying ubiquitin/ proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18, 538-543
69. Jiang, H., Sun, J., Xu, Q., Liu, Y., Wei, J., Young, C. Y., Yuan, H., and Lou, H. (2013) Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells. Cell Death Dis. 4, e761
70. Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., Padmanabhan, R., Hild, M., Berry, D. L., Garza, D., Hubbert, C. C., Yao, T. P., Baehrecke, E. H., and Taylor, J. P. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863
71. Shao, Y., Gao, Z., Marks, P. A., and Jiang, X. (2004) Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 101, 18030-18035
72. Yamamoto, S., Tanaka, K., Sakimura, R., Okada, T., Nakamura, T., Li, Y., Takasaki, M., Nakabeppu, Y., and Iwamoto, Y. (2008) Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines. Anticancer Res. 28, 1585-1591
73. Ren, Y., Huang, F., Liu, Y., Yang, Y., Jiang, Q., and Xu, C. (2009) Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep. 42, 599-604
74. Park, S. H., Kim, J. H., Chi, G. Y., Kim, G. Y., Chang, Y. C., Moon, S. K., Nam, S. W., Kim, W. J., Yoo, Y. H., and Choi, Y. H. (2012) Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species. Toxicol. Lett. 212, 252-261
75. Klionsky, D. J. , Abdalla, F. C. , Abeliovich, H. , Abraham, R. T. , Acevedo- Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre- Ghiso, J. A., Ahn, H. J., Ait-Mohamed, O., Ait-Si-Ali, S., Akematsu, T., Akira, S., Al-Younes, H. M., Al-Zeer, M. A., Albert, M. L., Albin, R. L., Alegre-Abarrategui, J., Aleo, M. F., Alirezaei, M., Almasan, A., Almonte- Becerril, M., Amano, A., Amaravadi, R., Amarnath, S., Amer, A. O., An-drieu- Abadie, N., Anantharam, V., Ann, D. K., Anoopkumar-Dukie, S., Aoki, H., Apostolova, N., Arancia, G., Aris, J. P., Asanuma, K., Asare, N. Y., Ashida, H., Askanas, V., Askew, D. S., Auberger, P., Baba, M., Backues, S. K., Baehrecke, E. H., Bahr, B. A., Bai, X. Y., Bailly, Y., Baiocchi, R., Baldini, G., Balduini, W., Ballabio, A., Bamber, B. A., Bampton, E. T., Banhegyi, G., Bartholomew, C. R., Bassham, D. C., Bast, R. C., Jr., Batoko, H., Bay, B. H., Beau, I., Bechet, D. M., Begley, T. J., Behl, C., Behrends, C., Bekri, S., Bellaire, B., Bendall, L. J., Benetti, L., Berliocchi, L., Bernardi, H., Bernassola, F., Besteiro, S., Bhatia-Kissova, I., Bi, X., Biard-Piechaczyk, M., Blum, J. S., Boise, L. H., Bonaldo, P., Boone, D. L., Bornhauser, B. C., Bortoluci, K. R., Bossis, I., Bost, F., Bourquin, J. P., Boya, P., Boyer-Guittaut, M., Bozhkov, P. V., Brady, N. R., Brancolini, C., Brech, A., Brenman, J. E., Brennand, A., Bresnick, E. H., Brest, P., Bridges, D., Bristol, M. L., Brookes, P. S., Brown, E. J., Brumell, J. H., et.al.(2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544
76. Fehrenbacher, N., and Jäättelä, M. (2005) Lysosomes as targets for cancer therapy. Cancer Res. 65, 2993-2995
77. Ishiguro, K., Ando, T., and Goto, H. (2008) Novel application of 4-nitro- 7-(1-piperazinyl)-2,1,3-benzoxadiazole to visualize lysosomes in live cells. BioTechniques 45, 465, 467-468
78. Ip, C. (1998) Lessons from basic research in selenium and cancer prevention. J. Nutr. 128, 1845-1854
79. Kassam, S., Goenaga-Infante, H., Maharaj, L., Hiley, C. T., Juliger, S., and Joel, S. P. (2011) Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines. Cancer Chemother. Pharmacol. 68, 815-821
80. Kice, J. L., and Lee, T. W. S. (1978) Oxidation-reduction reactions of organoselenium compounds: 1: mechanism of the reaction between seleninic acids and thiols. J. Am. Chem. Soc. 100, 5094-5102
81. Talbot, S., Nelson, R., and Self, W. T. (2008) Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia. Br. J. Pharmacol. 154, 940-948
82. Koch-Weser, J., and Sellers, E. M. (1976) Binding of drugs to serum albumin (first of two parts). N. Engl. J. Med. 294, 311-316
83. Koch-Weser, J., and Sellers, E. M. (1976) Drug therapy. Binding of drugs to serum albumin (second of two parts). N. Engl. J. Med. 294, 526-531
84. Levine, B., Mizushima, N., and Virgin, H. W. (2011) Autophagy in immunity and inflammation. Nature 469, 323-335
85. Kaeck, M., Lu, J., Strange, R., Ip, C., Ganther, H. E., and Thompson, H. J. (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem. Pharmacol. 53, 921-926
86. Lu, J., Jiang, C., Kaeck, M., Ganther, H., Vadhanavikit, S., Ip, C., and Thompson, H. (1995) Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem. Pharmacol. 50, 213-219
87. Li, K., Mandai, M., Hamanishi, J., Matsumura, N., Suzuki, A., Yagi, H., Yamaguchi, K., Baba, T., Fujii, S., and Konishi, I.(2009) Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol. Immunother. 58, 641-652
88. Groh, V., Wu, J., Yee, C., and Spies, T. (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature 419, 734-738